Previous close | 17.61 |
Open | 17.68 |
Bid | 17.84 x 100 |
Ask | 17.90 x 100 |
Day's range | 17.45 - 18.05 |
52-week range | 10.65 - 22.09 |
Volume | |
Avg. volume | 373,714 |
Market cap | 1.268B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | 137.54 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just...
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]